查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1390682

羊膜市场：2023-2028 年全球产业趋势、份额、规模、成长、机会与预测

Amniotic Membrane Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 140 Pages | 商品交期: 2-3个工作天内

价格

抽象的

2022年全球羊膜市场规模达14亿美元。展望未来， IMARC Group预计到2028年市场规模将达到24亿美元，2022-2028年复合年增长率（CAGR）为9.40%。对微创（MI）治疗的日益青睐、糖尿病和类风湿关节炎等多种慢性疾病的盛行率上升，以及专科诊所和医院的扩张是推动市场的一些主要因素。

羊膜是胎盘的最内层，由厚的基底膜和无血管基质组成。它是一种源自胎盘的生物组织，由于其独特的特性而用于医疗应用。它透过调节发炎反应来减少炎症，并最大限度地减少组织中的纤维化和疤痕。它可以舒缓疼痛的伤口和烧伤，并缩短其癒合时间。它安全且耐受性良好，排斥率低，广泛用于角膜溃疡等眼表疾病的手术。它还用作生物敷料，以减少粘连并促进恢復。

人们对微创 (MI) 治疗的日益青睐导緻羊膜在各种外科手术中的利用率不断提高。此外，医疗基础设施的成长以及专科诊所和医院的扩张为羊膜疗法的实施提供了更多机会。除此之外，各种领先的市场参与者都专注于併购（M&A），以扩大影响力、分享专业知识并进入新市场。此外，公司正在积极使其产品线多样化，提供适合各种手术和治疗需求的羊膜。此外，一些国家的政府正在加强对医疗保健专业人员和患者进行有关羊膜的好处和应用的教育，这提供了良好的市场前景。

羊膜市场趋势/驱动因素：

对再生医学的需求不断增加

糖尿病和类风湿性关节炎等几种慢性疾病的盛行率不断上升，导致慢性伤口和溃疡，增加了对有效治疗方法的需求。羊膜提供了一种创新的解决方案并刺激癒合过程。除此之外，全球老年人口不断增长，极易受到各种健康状况的影响，这推动了对促进更快癒合和组织再生的治疗的需求。此外，骨科和牙科等各种医学专业越来越多地采用羊膜，这对市场产生了积极影响。此外，羊膜促进细胞生长和减少发炎的能力正在推动其在其他再生治疗中的采用。

医疗程序的技术进步

先进技术的整合正在导緻羊膜的开发提高效率和功效。现代技术确保维持必需的生长因子和癒合特性，从而增强其在各个医学领域的适用性。羊膜与干细胞疗法和三维（3D）生物列印等尖端治疗方法的兼容性提供了良好的市场前景。这些整合可以实现更个人化和有效的治疗，并提高患者护理的品质。除此之外，改进的保存方法允许更长的保质期和更广泛的分销，这正在增加其在各个地区和医疗保健系统中的采用。

支持性监管环境

各国监管机构正在认识到羊膜的治疗价值，并针对羊膜的提取、加工、保存和应用实施明确且明确的指南。这些准则确保实践的一致性并维护产品的品质。除此之外，监管机构正在积极监控市场，以确保遵守所有相关规则和标准。定期检查、审计和报告要求有助于维护行业的信任和诚信。此外，他们还提供支持性政策，包括赠款、激励措施和公私合作伙伴关係，鼓励该领域的研究和发展。与研究机构的合作可以推动创新并将新颖的产品和疗法推向市场。

羊膜产业细分：

IMARC Group提供了全球羊膜市场报告各细分市场的主要趋势分析，以及 2023-2028 年全球、区域和国家层面的预测。我们的报告根据产品、应用和最终用户对市场进行了分类。

按产品划分：

冷冻保存羊膜

冻干羊膜

冻存羊膜占据市场主导地位

该报告根据产品提供了详细的市场细分和分析。这包括冷冻保存的羊膜和冷冻干燥羊膜。根据该报告，冷冻保存的羊膜代表了最大的部分。

它的保质期很长，可以让医院和诊所保持库存，而不会有降解的风险。它还易于储存、简化物流并减少浪费。此外，它有助于维持羊膜的生物完整性并增强羊膜的治疗效果。这种保留自然癒合特性的能力吸引了医疗保健提供者。除此之外，监管机构正在认识到低温保存的好处，并积极提供支持性指导方针和批准。监管机构的支持正在促进不同地区采用冷冻羊膜。

按应用划分：

手术伤口

眼科

其他的

手术伤口占大部分市场份额

报告还提供了基于应用程式的详细市场细分和分析。这包括手术伤口、眼科伤口等。报告称，手术伤口占据了大部分市场。不断增加的道路事故和重大运动伤害导致各个医学学科的择期手术和紧急手术数量增加，从而促进了对有效伤口护理的需求。此外，外科手术的技术进步使得更复杂和更多的手术能够以最佳效率进行。除此之外，人们越来越关注尽量减少术后感染和併发症，这推动了对高品质伤口护理产品的需求。人们越来越意识到感染预防和控制的重要性，这鼓励医疗保健提供者和患者选择最佳的伤口护理解决方案。此外，人们越来越注重有效癒合且不留明显疤痕，这导致了专门为手术伤口设计的伤口护理产品的创新。

按最终用户划分：

医院

门诊手术中心

专科诊所

研究中心和实验室

医院占最大市场份额

报告还提供了基于最终用户的详细市场细分和分析。这包括医院、门诊手术中心、专科诊所、研究中心和实验室。报告显示，医院占据了最大的市场。他们拥有专门的医疗专业人员和训练有素的工作人员来处理各种医疗状况。由于配备了技术先进的医疗设备，他们可以提供增强的诊断和治疗程序。除此之外，他们还提供紧急医疗服务并处理紧急和危及生命的情况，这提供了良好的市场前景。此外，许多医院与保险公司建立了关係，为患者提供更轻鬆、更全面的保险，这使得许多人更容易获得医院护理。此外，各地区的医院都得到政府的资助和支持，这确保了更广泛的人群获得基本的医疗服务。

按地区划分：

北美洲

美国

加拿大

亚太

中国

日本

印度

韩国

澳洲

印尼

其他的

欧洲

德国

法国

英国

义大利

西班牙

俄罗斯

其他的

拉丁美洲

巴西

墨西哥

其他的

中东和非洲

北美表现出明显的主导地位，占据最大的羊膜市场份额

该报告还对所有主要区域市场进行了全面分析，其中包括北美（美国和加拿大）；亚太地区（中国、日本、印度、韩国、澳洲、印尼等）；欧洲（德国、法国、英国、义大利、西班牙、俄罗斯等）；拉丁美洲（巴西、墨西哥等）；以及中东和非洲。报告称，北美占据了最大的市场份额，因为该地区拥有领先的研究机构和生物技术公司，积极投资于包括羊膜在内的再生医学的研发（R＆D）活动。此外，该地区拥有高度发展的医疗保健系统，拥有最先进的设施和技术，推动创新并促进羊膜等先进医疗产品的采用。除此之外，北美针对羊膜产品开发、批准和使用的支持性监管指南正在鼓励製造商扩大其市场范围。此外，医院、研究机构和生物技术公司之间的合作正在增强该地区的创新和市场渗透。

竞争格局：

该公司目前正在进行各种活动，以扩大这种独特生物材料的范围和效率。他们从胎盘中提取羊膜，并在严格控制的条件下进行处理。此外，他们正在进行严格的研发，探索羊膜在再生医学中应用的新可能性。除此之外，他们还不断努力增强羊膜的潜力，改善新疗法的前景，并继续支持医疗保健和患者福祉的更广泛目标。此外，许多公司积极参与对医疗保健提供者进行有关羊膜的好处和应用的教育。

该报告对市场竞争格局进行了全面分析。也提供了所有主要公司的详细资料。市场上的一些主要参与者包括：

羊膜科技有限公司

Amniox 医疗公司（TissueTech 公司）

创世纪生物製品公司

人类再生技术有限公司

Integra生命科学控股公司

卡泰纳产品公司

米迈德克斯集团

下一个生物科学公司

斯凯生物製品控股有限公司

施乐辉公司

Surgenex有限责任公司

文特里斯医疗有限公司

莱特医疗集团 (Stryker BV)。

最近的发展：

2022 年 2 月，Amnio Technology LLC 推出了两款新的 PalinGen 膜产品：PalinGen 双层膜和双层 PalinGen X-膜。它们的操作最少、同源使用且不含绒毛膜。

2021 年 6 月，MiMedx 集团在日本获得报销批准，成为该国第一个也是唯一一个获准使用的羊膜组织产品。

本报告回答的关键问题

  • 2022年全球羊膜市场规模是多少
  • 2023-2028年全球羊膜市场的预期成长率是多少
  • 推动全球羊膜市场的关键因素是什么
  • COVID-19 对全球羊膜市场有何影响
  • 基于产品的全球羊膜市场区隔是怎样的
  • 基于应用的全球羊膜市场区隔如何
  • 基于最终用户的全球羊膜市场的细分如何
  • 全球羊膜市场的重点区域有哪些
  • 谁是全球羊膜市场的主要参与者/公司

本报告回答的关键问题

  • 2022年全球羊膜市场规模有多大？
  • 2023-2028年全球羊膜市场的预期成长率是多少？
  • 推动全球羊膜市场的关键因素是什么？
  • COVID-19 对全球羊膜市场有何影响？
  • 基于产品的全球羊膜市场区隔如何？
  • 全球羊膜市场基于应用的细分情况如何？
  • 基于最终用户的全球羊膜市场的细分情况如何？
  • 全球羊膜市场的重点区域有哪些？
  • 全球羊膜市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球羊膜市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：按产品分類的市场区隔

  • 冷冻保存羊膜
    • 市场走向
    • 市场预测
  • 冻干羊膜
    • 市场走向
    • 市场预测

第 7 章：按应用分類的市场区隔

  • 手术伤口
    • 市场走向
    • 市场预测
  • 眼科
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 8 章：最终用户的市场区隔

  • 医院
    • 市场走向
    • 市场预测
  • 门诊手术中心
    • 市场走向
    • 市场预测
  • 专科诊所
    • 市场走向
    • 市场预测
  • 研究中心和实验室
    • 市场走向
    • 市场预测

第 9 章：按地区分類的市场区隔

  • 北美洲
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳洲
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 按国家/地区分類的市场细分
    • 市场预测

第 10 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格分析

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Amnio Technology LLC
    • Amniox Medical Inc. (TissueTech Inc.)
    • Genesis Biologics
    • Human Regenerative Technologies LLC
    • Integra LifeSciences Holdings Corporation
    • Katena Products Inc.
    • MiMedx Group
    • Next Biosciences
    • Skye Biologics Holdings LLC
    • Smith & Nephew plc
    • Surgenex LLC
    • Ventris Medical LLC
    • Wright Medical Group NV (Stryker BV)
Product Code: SR112023A4503

Abstract

The global amniotic membrane market size reached US$ 1.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.4 Billion by 2028, exhibiting a growth rate (CAGR) of 9.40% during 2022-2028. The increasing preference for minimally invasive (MI) treatments, rising prevalence of several chronic conditions like diabetes and rheumatoid arthritis, and the expansion of specialized clinics and hospitals are some of the major factors propelling the market.

The amniotic membrane is the innermost layer of the placenta, which consists of a thick basement membrane and an avascular stromal matrix. It is a biological tissue derived from the placenta and utilized in medical applications due to its unique properties. It reduces inflammation by modulating inflammatory responses and minimizes fibrosis and scarring in tissues. It provides a soothing effect on painful wounds and burns and reduces their healing times. It is safe and well-tolerated, with low rejection rates and widely used in surgeries for ocular surface disorders, such as corneal ulcers. It is also employed as a biological dressing to reduce adhesions and enhance recovery.

The increasing preference for minimally invasive (MI) treatments is resulting in the increasing utilization of the amniotic membrane in various surgical procedures. Additionally, growth in healthcare infrastructure and the expansion of specialized clinics and hospitals are offering more opportunities for the implementation of amniotic membrane therapies. Apart from this, various leading market players are focusing on mergers and acquisitions (M&A) to expand their reach, share expertise, and access new markets. Furthermore, companies are actively diversifying their product lines, offering amniotic membranes tailored for various surgical and therapeutic needs. Moreover, governments of several countries are increasing their efforts to educate healthcare professionals and patients about the benefits and applications of amniotic membranes, which is offering a favorable market outlook.

Amniotic Membrane Market Trends/Drivers:

Increasing demand for regenerative medicine

The rising prevalence of several chronic conditions like diabetes and rheumatoid arthritis, leading to chronic wounds and ulcers is increasing the need for effective treatment methods. Amniotic membranes offer an innovative solution and stimulate the healing process. Apart from this, the growing global geriatric population, which is highly susceptible to various health conditions is driving the need for treatments that promote faster healing and tissue regeneration. Furthermore, the increasing adoption of amniotic membranes in various medical specialties like orthopedics and dental medicine is positively influencing the market. Moreover, the ability of the amniotic membrane to facilitate cellular growth and decrease inflammation is driving its adoption in other regenerative treatments.

Technological advancements in medical procedures

The integration of advanced technologies is resulting in the development of amniotic membranes with increased efficiency and efficacy. Modern techniques ensure that essential growth factors and healing properties are maintained, enhancing their applicability in various medical domains. The compatibility of the amniotic membrane with cutting-edge treatments, such as stem cell therapies and three-dimensional (3D) bioprinting, is offering a favorable market outlook. These integrations allow for more personalized and effective treatments and enhance the quality of patient care. Apart from this, improved preservation methods allow for longer shelf life and wider distribution, which is increasing its adoption across various regions and healthcare systems.

Supportive regulatory environment

Regulatory bodies of various countries are recognizing the therapeutic value of the amniotic membrane and implementing clear and well-defined guidelines for the extraction, processing, preservation, and application of amniotic membranes. These guidelines ensure uniformity in practices and uphold the quality of products. Apart from this, regulatory authorities are actively monitoring the market to ensure compliance with all relevant rules and standards. Regular inspections, audits, and reporting requirements help maintain trust and integrity in the industry. Furthermore, they are offering supportive policies, which include grants, incentives, and public-private partnerships that encourage research and development in the field. Collaborative efforts with research institutions can drive innovation and bring novel products and therapies to market.

Amniotic Membrane Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global amniotic membrane market report, along with forecasts at the global, regional and country levels from 2023-2028. Our report has categorized the market based on product, application and end user.

Breakup by Product:

Cryopreserved Amniotic Membrane

Lyophilization Amniotic Membrane

Cryopreserved amniotic membrane dominates the market

The report has provided a detailed breakup and analysis of the market based on the product. This includes cryopreserved amniotic membrane and lyophilization amniotic membrane. According to the report, cryopreserved amniotic membrane represented the largest segment.

It has a long shelf life and it allows hospitals and clinics to maintain an inventory without the risk of degradation. It also offers ease of storage, simplifies logistics, and reduces waste. Additionally, it aids in maintaining the biological integrity of the amniotic membrane and enhancing the therapeutic effectiveness of the membrane. This ability to retain the natural healing properties is attracting healthcare providers. Apart from this, regulatory bodies are recognizing the benefits of cryopreservation and are actively providing supportive guidelines and approvals. This support from regulatory authorities is promoting the adoption of cryopreserved amniotic membranes across different regions.

Breakup by Application:

Surgical Wounds

Ophthalmology

Others

Surgical wounds account for the majority of the market share

A detailed breakup and analysis of the market based on the application has also been provided in the report. This includes surgical wounds, ophthalmology, and others. According to the report, surgical wounds hold the majority of the market share. Increasing road accidents and major sports injuries are leading to a rise in elective and emergency surgeries across various medical disciplines, which is catalyzing the need for effective wound care. Additionally, technological advancements in surgical procedures are allowing for more complex and numerous surgeries to be performed with optimal efficiency. Apart from this, the rising focus on minimizing post-operative infections and complications is driving the demand for high-quality wound care products. The growing awareness about the importance of infection prevention and control is encouraging healthcare providers and patients to opt for optimal wound care solutions. Furthermore, rising preferences for effective healing without significant scarring is leading to innovations in wound care products specifically designed for surgical wounds.

Breakup by End User:

Hospitals

Ambulatory Surgical Centers

Specialized Clinics

Research Centers and Laboratory

Hospitals hold the largest share of the market

A detailed breakup and analysis of the market based on the end user has also been provided in the report. This includes hospitals, ambulatory surgical centers, specialized clinics, and research centers and laboratory. According to the report, hospitals accounted for the largest market share. They have specialized medical professionals and skilled staff trained to deal with various medical conditions. They can offer enhanced diagnostic and therapeutic procedures as they are equipped with technologically advanced medical equipment. Apart from this, they provide emergency medical services and handle urgent and life-threatening situations, which is offering a favorable market outlook. Furthermore, many hospitals have established relationships with insurance providers, facilitating easier and more comprehensive coverage for patients, which makes hospital-based care more accessible for many individuals. Moreover, hospitals in various regions receive government funding and support, which ensures the availability of essential healthcare services to the wider population.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance, accounting for the largest amniotic membrane market share

The report has also provided a comprehensive analysis of all the major regional markets, which includes North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and Others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and Others); Latin America (Brazil, Mexico, and Others); and the Middle East and Africa. According to the report, North America accounted for the largest market share since the region is home to leading research institutions and biotechnology companies that actively invest in the research and development (R&D) activities of regenerative medicine, including amniotic membranes. Additionally, the region has a highly developed healthcare system with state-of-the-art facilities and technology, which drives innovation and facilitates the adoption of advanced medical products, such as amniotic membranes. Apart from this, supportive regulatory guidelines for the development, approval, and use of amniotic membrane products in North America is encouraging manufacturers to expand their market reach. Furthermore, collaborations between hospitals, research institutions, and biotechnology companies is enhancing innovation and market penetration in the region.

Competitive Landscape:

Companies are currently engaging in a variety of activities to expand the scope and efficiency of this unique biological material. They are extracting the amniotic membrane from the placenta and are processing it under carefully controlled conditions. Additionally, they are conducting rigorous R&D, exploring new possibilities for amniotic membrane use in regenerative medicine. Apart from this, they are working continuously to enhance the potential of the amniotic membrane, improving the prospects of new therapies, and continuing to support the broader goals of healthcare and patient well-being. Furthermore, many companies are actively involved in educating healthcare providers about the benefits and applications of the amniotic membrane.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Amnio Technology LLC

Amniox Medical Inc. (TissueTech Inc.)

Genesis Biologics

Human Regenerative Technologies LLC

Integra LifeSciences Holdings Corporation

Katena Products Inc.

MiMedx Group

Next Biosciences

Skye Biologics Holdings LLC

Smith & Nephew plc

Surgenex LLC

Ventris Medical LLC

Wright Medical Group N.V. (Stryker B.V.).

Recent Developments:

In February 2022, Amnio Technology LLC launched two new PalinGen membrane products, PalinGen Dual-Layer Membrane and Dual Layer PalinGen X-Membrane. They are minimally manipulated, homologous use and chorion-free.

In June 2021, MiMedx Group received reimbursement approval in Japan, making it the first and only amniotic tissue product approved for use in the country.

Key Questions Answered in This Report

  • 1. What was the size of the global amniotic membrane market in 2022?
  • 2. What is the expected growth rate of the global amniotic membrane market during 2023-2028?
  • 3. What are the key factors driving the global amniotic membrane market?
  • 4. What has been the impact of COVID-19 on the global amniotic membrane market?
  • 5. What is the breakup of the global amniotic membrane market based on the product?
  • 6. What is the breakup of the global amniotic membrane market based on the application?
  • 7. What is the breakup of the global amniotic membrane market based on the end user?
  • 8. What are the key regions in the global amniotic membrane market?
  • 9. Who are the key players/companies in the global amniotic membrane market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Amniotic Membrane Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Cryopreserved Amniotic Membrane
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Lyophilization Amniotic Membrane
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Surgical Wounds
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Ophthalmology
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Ambulatory Surgical Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Specialized Clinics
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Research Centers and Laboratory
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Amnio Technology LLC
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Amniox Medical Inc. (TissueTech Inc.)
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Genesis Biologics
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Human Regenerative Technologies LLC
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Integra LifeSciences Holdings Corporation
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Katena Products Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 MiMedx Group
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 Next Biosciences
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Skye Biologics Holdings LLC
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Smith & Nephew plc
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Surgenex LLC
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 Ventris Medical LLC
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
    • 14.3.13 Wright Medical Group N.V. (Stryker B.V.)
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
      • 14.3.13.3 SWOT Analysis

List of Figures

  • Figure 1: Global: Amniotic Membrane Market: Major Drivers and Challenges
  • Figure 2: Global: Amniotic Membrane Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Amniotic Membrane Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Amniotic Membrane Market: Breakup by Product (in %), 2022
  • Figure 5: Global: Amniotic Membrane Market: Breakup by Application (in %), 2022
  • Figure 6: Global: Amniotic Membrane Market: Breakup by End User (in %), 2022
  • Figure 7: Global: Amniotic Membrane Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Amniotic Membrane (Cryopreserved Amniotic Membrane) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Amniotic Membrane (Cryopreserved Amniotic Membrane) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Amniotic Membrane (Lyophilization Amniotic Membrane) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Amniotic Membrane (Lyophilization Amniotic Membrane) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Amniotic Membrane (Surgical Wounds) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Amniotic Membrane (Surgical Wounds) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Amniotic Membrane (Ophthalmology) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Amniotic Membrane (Ophthalmology) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Amniotic Membrane (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Amniotic Membrane (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Amniotic Membrane (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Amniotic Membrane (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Amniotic Membrane (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Amniotic Membrane (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Amniotic Membrane (Specialized Clinics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Amniotic Membrane (Specialized Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Amniotic Membrane (Research Centers and Laboratory) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Amniotic Membrane (Research Centers and Laboratory) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: North America: Amniotic Membrane Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: North America: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: United States: Amniotic Membrane Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: United States: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Canada: Amniotic Membrane Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Canada: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Asia-Pacific: Amniotic Membrane Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Asia-Pacific: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: China: Amniotic Membrane Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: China: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: Japan: Amniotic Membrane Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: Japan: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: India: Amniotic Membrane Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: India: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: South Korea: Amniotic Membrane Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: South Korea: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: Australia: Amniotic Membrane Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: Australia: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: Indonesia: Amniotic Membrane Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: Indonesia: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Others: Amniotic Membrane Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Others: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Europe: Amniotic Membrane Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Europe: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Germany: Amniotic Membrane Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Germany: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: France: Amniotic Membrane Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: France: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: United Kingdom: Amniotic Membrane Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: United Kingdom: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Italy: Amniotic Membrane Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Italy: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Spain: Amniotic Membrane Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Spain: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Russia: Amniotic Membrane Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Russia: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Others: Amniotic Membrane Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Others: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Latin America: Amniotic Membrane Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Latin America: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Brazil: Amniotic Membrane Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Brazil: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Mexico: Amniotic Membrane Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Mexico: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Others: Amniotic Membrane Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Others: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Middle East and Africa: Amniotic Membrane Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Middle East and Africa: Amniotic Membrane Market: Breakup by Country (in %), 2022
  • Figure 74: Middle East and Africa: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Global: Amniotic Membrane Industry: SWOT Analysis
  • Figure 76: Global: Amniotic Membrane Industry: Value Chain Analysis
  • Figure 77: Global: Amniotic Membrane Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Amniotic Membrane Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Amniotic Membrane Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 3: Global: Amniotic Membrane Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 4: Global: Amniotic Membrane Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 5: Global: Amniotic Membrane Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Amniotic Membrane Market: Competitive Structure
  • Table 7: Global: Amniotic Membrane Market: Key Players